Frontiers in medicine · 2026
Prediction of moderate-to-severe postoperative thirst in general anesthesia patients based on automated machine learning and clinical nursing translation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhan Yi, Yang Siting, Wang Haoran
Аннотация
OBJECTIVE: To develop an Automated Machine Learning (AutoML)-based model for screening Moderate-to-Severe Postoperative Thirst (MSPOT) risk at surgery-to-PACU handover and a prototype clinical decision support system.
METHODS: This retrospective single-center cohort included 928 patients undergoing general anesthesia (training set: n = 650; held-out internal test set: n = 278). An Improved Wave Optics Optimizer (IWOO) framework integrated feature selection and hyperparameter optimization using demographic, preoperative, and intraoperative variables. Prediction was performed at anesthesia-to-PACU handover, after final intraoperative data became available and before routine postoperative NRS thirst assessment. Performance was evaluated using ROC-AUC, PR-AUC, calibration analysis, Brier score, and decision curve analysis (DCA). SHAP was used to summarize feature contributions.
RESULTS: In the held-out internal test set, the AutoML model achieved a ROC-AUC of 0.9053, PR-AUC of 0.9080, and Brier score of 0.129, outperforming conventional models. DCA showed greater net benefit across thresholds of 1%-95%. In same-center temporal validation, discrimination remained acceptable (ROC-AUC: 0.8807; PR-AUC: 0.8778), but calibration deteriorated (Brier score: 0.1924; intercept: -1.2250; slope: 0.5811), indicating average risk overestimation and overly extreme probabilities. Six predictors were identified: esmolol use, intraoperative blood loss, operation time, ASA classification, ERAS, and intraoperative fluid volume.
CONCLUSIONS: The AutoML model showed strong discrimination and transparent feature attribution. The prototype illustrates its potential use at PACU handover to prioritize early assessment and comfort-oriented thirst management. However, temporal miscalibration indicates that individualized probabilities are not ready for clinical decision-making without recalibration and subsequent prospective validation.
METHODS: This retrospective single-center cohort included 928 patients undergoing general anesthesia (training set: n = 650; held-out internal test set: n = 278). An Improved Wave Optics Optimizer (IWOO) framework integrated feature selection and hyperparameter optimization using demographic, preoperative, and intraoperative variables. Prediction was performed at anesthesia-to-PACU handover, after final intraoperative data became available and before routine postoperative NRS thirst assessment. Performance was evaluated using ROC-AUC, PR-AUC, calibration analysis, Brier score, and decision curve analysis (DCA). SHAP was used to summarize feature contributions.
RESULTS: In the held-out internal test set, the AutoML model achieved a ROC-AUC of 0.9053, PR-AUC of 0.9080, and Brier score of 0.129, outperforming conventional models. DCA showed greater net benefit across thresholds of 1%-95%. In same-center temporal validation, discrimination remained acceptable (ROC-AUC: 0.8807; PR-AUC: 0.8778), but calibration deteriorated (Brier score: 0.1924; intercept: -1.2250; slope: 0.5811), indicating average risk overestimation and overly extreme probabilities. Six predictors were identified: esmolol use, intraoperative blood loss, operation time, ASA classification, ERAS, and intraoperative fluid volume.
CONCLUSIONS: The AutoML model showed strong discrimination and transparent feature attribution. The prototype illustrates its potential use at PACU handover to prioritize early assessment and comfort-oriented thirst management. However, temporal miscalibration indicates that individualized probabilities are not ready for clinical decision-making without recalibration and subsequent prospective validation.